A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin
Xinliang Mao(Guangzhou Medical University), Aaron D. Schimmer(University of Toronto), Dwayne L. Barber(University of Toronto), Rose Hurren(Ontario Institute for Cancer Research), Seth J. Corey(The Ohio State University), Lisa Gillis(Ontario Institute for Cancer Research), Sheng‐Ben Liang(University Health Network), Kyle Lee(Ontario Institute for Cancer Research), Rodger E. Tiedemann(Mayo Clinic in Arizona), Yanina Eberhard(Ontario Institute for Cancer Research), Suzanne Trudel(Princess Margaret Cancer Centre), Shereen Ezzat(Princess Margaret Cancer Centre), Xuegong Zhu(Capital Medical University), Yuanxiao Zhu(Mayo Clinic in Arizona), Chang‐Xin Shi(Mayo Clinic in Arizona), Alessandro Datti(Mount Sinai Hospital), A. Keith Stewart(The University of Texas MD Anderson Cancer Center), Jeffery L. Wrana(Mount Sinai Hospital)
Cited by 57
Related Papers
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
|Cancer Cell|2014|1k
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635